These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18158220)

  • 1. Does dopaminergic reward system contribute to explaining comorbidity obesity and ADHD?
    Liu LL; Li BM; Yang J; Wang YW
    Med Hypotheses; 2008; 70(6):1118-20. PubMed ID: 18158220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does excessive daytime sleepiness contribute to explaining the association between obesity and ADHD symptoms?
    Cortese S; Konofal E; Dalla Bernardina B; Mouren MC; Lecendreux M
    Med Hypotheses; 2008; 70(1):12-6. PubMed ID: 17587509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity, attention deficit-hyperactivity disorder and the dopaminergic reward system.
    Campbell BC; Eisenberg D
    Coll Antropol; 2007 Mar; 31(1):33-8. PubMed ID: 17600916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alterations in the pattern of dopaminergic markers in attention-deficit/hyperactivity disorder].
    Díaz-Heijtz R; Mulas F; Forssberg H
    Rev Neurol; 2006 Feb; 42 Suppl 2():S19-23. PubMed ID: 16555214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity between ADHD and obesity: exploring shared mechanisms and clinical implications.
    Cortese S; Morcillo Peñalver C
    Postgrad Med; 2010 Sep; 122(5):88-96. PubMed ID: 20861592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention-deficit/hyperactivity disorder, iron deficiency, and obesity: is there a link?
    Cortese S; Angriman M
    Postgrad Med; 2014 Jul; 126(4):155-70. PubMed ID: 25141253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
    Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
    Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention-deficit/hyperactivity disorder: a selective overview.
    Biederman J
    Biol Psychiatry; 2005 Jun; 57(11):1215-20. PubMed ID: 15949990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlations between attention deficit hyperactivity disorder and obesity - a systematic review of the literature].
    Racicka E
    Psychiatr Pol; 2013; 47(1):89-102. PubMed ID: 23888747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient reinforcement learning in medial frontal cortex as a model of dopamine-related motivational deficits in ADHD.
    Silvetti M; Wiersema JR; Sonuga-Barke E; Verguts T
    Neural Netw; 2013 Oct; 46():199-209. PubMed ID: 23811383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focus on the positive: computational simulations implicate asymmetrical reward prediction error signals in childhood attention-deficit/hyperactivity disorder.
    Cockburn J; Holroyd CB
    Brain Res; 2010 Dec; 1365():18-34. PubMed ID: 20875804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of zinc in the treatment of hyperactivity disorder in children].
    Dodig-Curković K; Dovhanj J; Curković M; Dodig-Radić J; Degmecić D
    Acta Med Croatica; 2009 Oct; 63(4):307-13. PubMed ID: 20034331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alertness and feeding behaviors in ADHD: does the hypocretin/orexin system play a role?
    Cortese S; Konofal E; Lecendreux M
    Med Hypotheses; 2008 Nov; 71(5):770-5. PubMed ID: 18678446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention-deficit/hyperactivity disorder: is it time to reappraise the role of sugar consumption?
    Johnson RJ; Gold MS; Johnson DR; Ishimoto T; Lanaspa MA; Zahniser NR; Avena NM
    Postgrad Med; 2011 Sep; 123(5):39-49. PubMed ID: 21904085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses.
    Genro JP; Kieling C; Rohde LA; Hutz MH
    Expert Rev Neurother; 2010 Apr; 10(4):587-601. PubMed ID: 20367210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing comorbidity in adults with attention-deficit/hyperactivity disorder.
    Hornig M
    J Clin Psychiatry; 1998; 59 Suppl 7():69-75. PubMed ID: 9680055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues.
    Denney CB
    J Clin Child Psychol; 2001 Mar; 30(1):98-109. PubMed ID: 11294083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A psycho-genetic study of associations between the symptoms of binge eating disorder and those of attention deficit (hyperactivity) disorder.
    Davis C; Patte K; Levitan RD; Carter J; Kaplan AS; Zai C; Reid C; Curtis C; Kennedy JL
    J Psychiatr Res; 2009 Apr; 43(7):687-96. PubMed ID: 19041097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical bases and research in attention-deficit hyperactivity disorder].
    Díaz-Heijtz R
    Rev Neurol; 2002 Feb; 34 Suppl 1():S78-81. PubMed ID: 12447795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could treatment of iron deficiency both improve ADHD and reduce cardiovascular risk during treatment with ADHD drugs?
    Parisi P; Villa MP; Donfrancesco R; Miano S; Paolino MC; Cortese S
    Med Hypotheses; 2012 Aug; 79(2):246-9. PubMed ID: 22632845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.